Qualitative study of Oncology Clinicians’ Perceptions of Barriers to Offering Clinical Trials to Underserved Populations

INTRODUCTION: Cancer clinical trials represent the “gold standard” for advancing novel cancer therapies. Optimizing trial participation is critical to ensuring the generalizability of findings across patients, yet trial enrollment rates, particularly among minority and socioeconomically disadvantage...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Giselle K., Oberoi, Anjali R., Finkelstein-Fox, Lucy, Park, Elyse R., Nipp, Ryan D., Moy, Beverly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Disparities in Cancer Treatment and Outcome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510359/
https://www.ncbi.nlm.nih.gov/pubmed/37724824
http://dx.doi.org/10.1177/10732748231187829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510359/
https://www.ncbi.nlm.nih.gov/pubmed/37724824
http://dx.doi.org/10.1177/10732748231187829

Ejemplares similares